Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Comment by august202013on Nov 18, 2022 10:49am
129 Views
Post# 35110337

RE:RE:Meile knows yr end #’s. NOW

RE:RE:Meile knows yr end #’s. NOWAgreed on impending results on poor performance and skyrocketing OVERHEAD but still DON'T understand till TODAY how come HC won't BUY from Medmira back in 2020 when they already had the EUA ? But HC chose to BUY FROM US and AUST and also issued HC certification for products from many companies from other countries BUT NOT for Medmira ? Also recall a few companies give $50 million to try to develop vaccine ! Yes have to admit failed to cash out above 0.80 or 0.70 or 0.60... but worse continued to buy down from 0.40... Having said all that have to also agree Medmira after ISO certification is a different Medmira better prepared for the next wave BUT race against accumulation of OVERHEAD s kind of chicken and egg situation ? Still believe some technical rebound by year end could also be attributed from the long awaited EUA for their COVID19 TEST KIT PLUS application made on 30-12-2020
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse